{"DataElement":{"publicId":"5210991","version":"1","preferredName":"Renal Cell Carcinoma Histologic Primary Classification Type","preferredDefinition":"Text term to identify the kind of malignant neoplasm that affects the kidneys.","longName":"REN_CARC_HX_PRI_TYPE","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"2430076","version":"1","preferredName":"Renal Cell Carcinoma Histologic Primary Classification","preferredDefinition":"information relating to the histologic primary classification of renal cell carcinoma.","longName":"RCLCA_HIST_PRI_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2428360","version":"1","preferredName":"Renal Cell Carcinoma","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","longName":"C9385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0826-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2430074","version":"1","preferredName":"Histologic Primary Classification","preferredDefinition":"Of or relating to histology.:Occurring first in time or sequence; original. (American Heritage Dictionary):Classification; the grouping of things into classes or categories.","longName":"C25526:C25251:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05B23066-8F5E-1D7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-17","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-17","modifiedBy":"ONEDATA","dateModified":"2005-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05B23066-8F5F-1D7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-16","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5210412","version":"1","preferredName":"Renal Cell Carcinoma Histologic Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5210412v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-653C-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Translocation carcinoma (Xp11 or others)","valueDescription":"Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions","ValueMeaning":{"publicId":"5210414","version":"1","preferredName":"Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions","longName":"5210414","preferredDefinition":"A group of kidney carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2.  These translocations result in the creation of gene fusions involving the TFE3 gene.  Patients are usually children and young adults.  Morphologically, the malignant epithelial cells form papillary patterns.  The clinical behavior of this group of carcinomas is largely unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TFE3-Rearranged Renal Cell Carcinoma","conceptCode":"C27891","definition":"A group of renal cell carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2. These translocations result in the creation of gene fusions involving the TFE3 gene. Patients are usually children and young adults. Morphologically, the malignant epithelial cells form papillary patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-6549-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-6562-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Renal medullary carcinoma (WHO code: 8319/3)","valueDescription":"Kidney Medullary Carcinoma","ValueMeaning":{"publicId":"5210416","version":"1","preferredName":"Kidney Medullary Carcinoma","longName":"5210416","preferredDefinition":"A recently described type of renal carcinoma, affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Medullary Carcinoma","conceptCode":"C7572","definition":"A type of renal carcinoma affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-656F-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-6588-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Renal cell carcinoma, unclassified (WHO code: 8312/3)","valueDescription":"Unclassified Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118711","version":"1","preferredName":"Unclassified Renal Cell Carcinoma","longName":"5118711","preferredDefinition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unclassified Renal Cell Carcinoma","conceptCode":"C27892","definition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-3928-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-659C-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Multilocular clear cell renal carcinoma (WHO code: 8310/3)","valueDescription":"Multilocular Cystic Renal Cell Carcinoma","ValueMeaning":{"publicId":"5210418","version":"1","preferredName":"Multilocular Cystic Renal Cell Carcinoma","longName":"5210418","preferredDefinition":"A rare type of renal cell carcinoma.  It is a well-circumscribed multicystic mass without solid areas.  The inner lining of the cystic structures is composed of clear cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multilocular Cystic Renal Neoplasm of Low Malignant Potential","conceptCode":"C4524","definition":"A rare kidney neoplasm of low malignant potential.  It is a well-circumscribed multicystic mass without solid areas.  The inner lining of the cystic structures is composed of clear cells. It usually presents as a unilateral solitary mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-65AA-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-65C3-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Mucinous tubular and spindle cell carcinoma","valueDescription":"Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","ValueMeaning":{"publicId":"5210420","version":"1","preferredName":"Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","longName":"5210420","preferredDefinition":"A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular structures have a spindle cell appearance.  Patients are usually asymptomatic and occasionally they may present with hematuria or flank pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","conceptCode":"C39807","definition":"A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular structures have a spindle cell appearance.  Patients are usually asymptomatic and occasionally they may present with hematuria or flank pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-65D0-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-65E9-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Clear cell renal carcinoma (WHO code: 8310/3)","valueDescription":"Clear Cell Renal Cell Carcinoma","ValueMeaning":{"publicId":"3248533","version":"1","preferredName":"Clear Cell Renal Cell Carcinoma","longName":"3248533","preferredDefinition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Renal Cell Carcinoma","conceptCode":"C4033","definition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B9CF-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-65FD-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Chromophobe renal cell carcinoma (WHO code: 8317/3)","valueDescription":"Chromophobe Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118714","version":"1","preferredName":"Chromophobe Renal Cell Carcinoma","longName":"5118714","preferredDefinition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromophobe Renal Cell Carcinoma","conceptCode":"C4146","definition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical), eosinophilic, or oncocytic.  It has a much better prognosis than other renal cell carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-397C-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-6612-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Carcinoma of the collecting ducts of Bellini (WHO code:  8319/3)","valueDescription":"Carcinoma of the Collecting Ducts of Bellini","ValueMeaning":{"publicId":"2581666","version":"1","preferredName":"Carcinoma of the Collecting Ducts of Bellini","longName":"2581666","preferredDefinition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collecting Duct Carcinoma","conceptCode":"C6194","definition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-09","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-09","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-6627-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"},{"value":"Carcinoma associated with neuroblastoma","valueDescription":"Renal Cell Carcinoma Associated with Neuroblastoma","ValueMeaning":{"publicId":"5210422","version":"1","preferredName":"Renal Cell Carcinoma Associated with Neuroblastoma","longName":"5210422","preferredDefinition":"Renal cell carcinoma that develops in patients who are long-term survivors of childhood neuroblastoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma Associated with Neuroblastoma","conceptCode":"C100051","definition":"Renal cell carcinoma that develops in patients who are long-term survivors of childhood neuroblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-6635-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB1364C-664E-8128-E050-BB89AD436BE4","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"ONEDATA","dateModified":"2016-04-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-6526-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"HARTLEYG","dateModified":"2016-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736423","version":"1","longName":"Kidney Local Path Review","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FC41B0C-0D48-9B2A-E050-BB89AD430A54","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}